MA20150396A1 - Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs - Google Patents
Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocsInfo
- Publication number
- MA20150396A1 MA20150396A1 MA37970A MA37970A MA20150396A1 MA 20150396 A1 MA20150396 A1 MA 20150396A1 MA 37970 A MA37970 A MA 37970A MA 37970 A MA37970 A MA 37970A MA 20150396 A1 MA20150396 A1 MA 20150396A1
- Authority
- MA
- Morocco
- Prior art keywords
- combination
- adrenaline
- antidepressant
- shock treatment
- treatment
- Prior art date
Links
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 title abstract 4
- 230000001430 anti-depressive effect Effects 0.000 title abstract 2
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 238000002635 electroconvulsive therapy Methods 0.000 title 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010040560 shock Diseases 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
La présente invention concerne une nouvelle combinaison d'adrénaline avec un antidépresseur et l'utilisation de ladite combinaison en tant que composition pharmaceutique dans le traitement des chocs. La composition est destinée à être administrée par injection.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306207 | 2012-10-03 | ||
| PCT/EP2013/070598 WO2014053579A1 (fr) | 2012-10-03 | 2013-10-02 | Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MA20150396A1 true MA20150396A1 (fr) | 2015-11-30 |
| MA37970B1 MA37970B1 (fr) | 2016-06-30 |
| MA37970B2 MA37970B2 (fr) | 2017-10-31 |
Family
ID=47073380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA37970A MA37970B2 (fr) | 2012-10-03 | 2013-10-02 | Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20150306065A1 (fr) |
| EP (1) | EP2903607B1 (fr) |
| JP (1) | JP6419074B2 (fr) |
| KR (1) | KR102145786B1 (fr) |
| CN (1) | CN104780916B (fr) |
| AU (1) | AU2013326470B2 (fr) |
| BR (1) | BR112015007524B1 (fr) |
| CA (1) | CA2887330C (fr) |
| CY (1) | CY1119514T1 (fr) |
| DK (1) | DK2903607T3 (fr) |
| EA (1) | EA030763B1 (fr) |
| ES (1) | ES2647597T3 (fr) |
| HR (1) | HRP20171442T1 (fr) |
| HU (1) | HUE034638T2 (fr) |
| IL (1) | IL238120B (fr) |
| IN (1) | IN2015DN02849A (fr) |
| LT (1) | LT2903607T (fr) |
| MA (1) | MA37970B2 (fr) |
| MX (1) | MX359198B (fr) |
| NO (1) | NO2903607T3 (fr) |
| NZ (1) | NZ707124A (fr) |
| PH (1) | PH12015500755B1 (fr) |
| PL (1) | PL2903607T3 (fr) |
| PT (1) | PT2903607T (fr) |
| RS (1) | RS56392B1 (fr) |
| SG (1) | SG11201502645VA (fr) |
| SI (1) | SI2903607T1 (fr) |
| SM (1) | SMT201700502T1 (fr) |
| TN (1) | TN2015000126A1 (fr) |
| WO (1) | WO2014053579A1 (fr) |
| ZA (1) | ZA201502441B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4706649A1 (fr) | 2024-09-05 | 2026-03-11 | Bioprojet | Utilisation de l'adrénaline pour le traitement des chocs |
| EP4706648A1 (fr) | 2024-09-05 | 2026-03-11 | Bioprojet | Formulations d'adrénaline et d'antidépresseur |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3705942A (en) * | 1969-09-29 | 1972-12-12 | Ciba Geigy Corp | Treatment of glaucoma employing imipramine or desmethylimipramine |
| TW200744568A (en) * | 2006-02-28 | 2007-12-16 | Verus Pharmaceuticals Inc | Epinephrine dosing regimens |
| US20070293582A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
| JP5670196B2 (ja) * | 2007-11-16 | 2015-02-18 | バイセプト セラピューティクス、インク． | 紫斑を治療する組成物および方法 |
| SE533552C2 (sv) * | 2008-12-30 | 2010-10-26 | Igeloesa Transplantation Science Ab | Förfarande och lösning för behandling av en potentiell organdonator |
| US20100190860A1 (en) * | 2009-01-09 | 2010-07-29 | The Brigham And Women's Hospital, Inc. | Methods for selectively enhancing antinociceptive potency of local anesthetics |
| CN101987198B (zh) * | 2009-08-06 | 2014-08-13 | 北京美倍他药物研究有限公司 | 药物组合物 |
-
2013
- 2013-10-02 KR KR1020157010740A patent/KR102145786B1/ko active Active
- 2013-10-02 ES ES13771500.9T patent/ES2647597T3/es active Active
- 2013-10-02 HU HUE13771500A patent/HUE034638T2/en unknown
- 2013-10-02 US US14/433,549 patent/US20150306065A1/en not_active Abandoned
- 2013-10-02 MA MA37970A patent/MA37970B2/fr unknown
- 2013-10-02 CN CN201380057617.0A patent/CN104780916B/zh active Active
- 2013-10-02 HR HRP20171442TT patent/HRP20171442T1/hr unknown
- 2013-10-02 AU AU2013326470A patent/AU2013326470B2/en active Active
- 2013-10-02 EA EA201500374A patent/EA030763B1/ru not_active IP Right Cessation
- 2013-10-02 MX MX2015004323A patent/MX359198B/es active IP Right Grant
- 2013-10-02 EP EP13771500.9A patent/EP2903607B1/fr active Active
- 2013-10-02 IN IN2849DEN2015 patent/IN2015DN02849A/en unknown
- 2013-10-02 NZ NZ707124A patent/NZ707124A/en unknown
- 2013-10-02 LT LTEP13771500.9T patent/LT2903607T/lt unknown
- 2013-10-02 CA CA2887330A patent/CA2887330C/fr active Active
- 2013-10-02 PT PT137715009T patent/PT2903607T/pt unknown
- 2013-10-02 RS RS20170973A patent/RS56392B1/sr unknown
- 2013-10-02 SM SM20170502T patent/SMT201700502T1/it unknown
- 2013-10-02 PL PL13771500T patent/PL2903607T3/pl unknown
- 2013-10-02 BR BR112015007524-0A patent/BR112015007524B1/pt active IP Right Grant
- 2013-10-02 NO NO13771500A patent/NO2903607T3/no unknown
- 2013-10-02 WO PCT/EP2013/070598 patent/WO2014053579A1/fr not_active Ceased
- 2013-10-02 SG SG11201502645VA patent/SG11201502645VA/en unknown
- 2013-10-02 DK DK13771500.9T patent/DK2903607T3/en active
- 2013-10-02 JP JP2015535014A patent/JP6419074B2/ja active Active
- 2013-10-02 SI SI201330817T patent/SI2903607T1/sl unknown
-
2015
- 2015-04-02 IL IL238120A patent/IL238120B/en active IP Right Grant
- 2015-04-02 TN TNP2015000126A patent/TN2015000126A1/fr unknown
- 2015-04-06 PH PH12015500755A patent/PH12015500755B1/en unknown
- 2015-04-10 ZA ZA2015/02441A patent/ZA201502441B/en unknown
-
2017
- 2017-10-31 CY CY20171101135T patent/CY1119514T1/el unknown
-
2018
- 2018-12-18 US US16/223,750 patent/US10952987B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA033811B1 (ru) | Стабильные бесконсервантные мидриатические и противовоспалительные растворы для инъекций | |
| MX370903B (es) | Composiciones de ácido percarboxílico estables y sus usos. | |
| MA38273A1 (fr) | Thérapie de combinaison avec des anticorps anti-her3 | |
| MA39211B1 (fr) | Composés tricycliques comme agents anti-cancers | |
| MX395719B (es) | Composiciones y métodos para el uso de ésteres de forbol. | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
| BR112015014034A2 (pt) | inibidores de irak e usos dos mesmos | |
| MA34457B1 (fr) | Combinaison d'un composé glyt1 avec des agents antipsychotiques | |
| DOP2013000130A (es) | Compuestos de pirimidinona para uso en el tratamiento de las enfermedades o condiciones mediada por lp - pla2 | |
| MA38403A1 (fr) | Nouveaux dérivés de pyrazole modulateurs specifiques de cb2 | |
| MA37990B1 (fr) | Benzamides | |
| MA38460A1 (fr) | Dérivés de la purine en tant qu'agonistes du récepteur cb2 | |
| CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
| PE20150190A1 (es) | Formulacion farmaceutica | |
| MX2022001796A (es) | Metodos y composiciones para inhibir los sintomas asociados con la veisalgia. | |
| MA37970B2 (fr) | Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs | |
| FR3019465B1 (fr) | Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen | |
| MA45639B1 (fr) | Combinaison d'antagonistes purs du récepteur 5-ht6 avec des inhibiteurs d'acétylcholinestérase | |
| AR088600A1 (es) | Composiciones de yodo-povidona | |
| MA38931B1 (fr) | Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose | |
| MA45990B1 (fr) | Combinaison d'agonistes inverses du récepteur de l'histamine-3 avec des inhibiteurs de l'acétylcholinestérase | |
| EA201500155A1 (ru) | Фармацевтические композиции, содержащие ипидакрин, и их применение для лечения нарушений потенции и нарушений других форм половой активности | |
| FR3015287B1 (fr) | Combinaison de bezafibrate et de resveratrol pour le traitement et la prevention des maladies impliquant un dysfonctionnement energetique des mitochondries. | |
| MA35029B1 (fr) | Traitement de l'infection par le virus de l'hépatite c avec l'alisporivir | |
| MA40553B1 (fr) | Derives de pyrimidine eventuellement condensee utiles dans le traitement de maladies inflammatoires, metaboliques, oncologiques et auto-immunes |